Causeway Therapeutics
PrivateLast Round
VC Round
Feb 27, 2023
Total Funding Raised
$6.36M
Company Overview
Causeway Therapeutics is a clinical-stage biotechnology company developing novel microRNA-based medicines to treat tendon disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Causeway Therapeutics Comparables
Compare Causeway Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| miRecule, Inc. | 63% | |
| Viridian Therapeutics | 59% | |
| Zimmer Biomet | 59% |
Causeway Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 27, 2023 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Jun 1, 2019 | ||||
| Seed | Sep 27, 2018 | ||||
| Grant | May 30, 2018 | ||||
Seed | Aug 3, 2017 |
Causeway Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Mediqventures | VC Round, Seed |
| Scottish National Investment Bank | Seed, VC Round |
| Glasgow University Holdings Ltd | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 424% MoM, reaching 1.2K.
Causeway Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access